{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:10:51Z","timestamp":1790698251798,"version":"4.1.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"13","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01AI115497"],"award-info":[{"award-number":["U01AI115497"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.vaccine.2019.02.022","type":"journal-article","created":{"date-parts":[[2019,2,20]],"date-time":"2019-02-20T13:28:53Z","timestamp":1550669333000},"page":"1807-1818","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Non-pathogenic Borrelia burgdorferi expressing Treponema pallidum TprK and Tp0435 antigens as a novel approach to evaluate syphilis vaccine candidates"],"prefix":"10.1016","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0592-0693","authenticated-orcid":false,"given":"Nikhat","family":"Parveen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark C.","family":"Fernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Austin M.","family":"Haynes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui-Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. Charmie","family":"Godornes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arturo","family":"Centurion-Lara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3889-7274","authenticated-orcid":false,"given":"Lorenzo","family":"Giacani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2019.02.022_b0005","unstructured":"WHO. Prevalence and incidence of selected sexually transmitted infections Chlamydia trachomatis, Neisseria gonorrhoeae, syphilis and Trichomonas vaginalis: methods and results used by WHO to generate 2005 estimates. Geneva: World Health Organization; 2011."},{"issue":"1","key":"10.1016\/j.vaccine.2019.02.022_b0010","doi-asserted-by":"crossref","DOI":"10.7189\/jogh.01.010402","article-title":"An estimate of syphilis incidence in Eastern Europe","volume":"2","author":"Herbert","year":"2012","journal-title":"J Glob Health"},{"issue":"29","key":"10.1016\/j.vaccine.2019.02.022_b0015","doi-asserted-by":"crossref","DOI":"10.2807\/ese.17.29.20224-en","article-title":"Rapid increase in gonorrhoea and syphilis diagnoses in England in 2011","volume":"17","author":"Savage","year":"2012","journal-title":"Euro Surveill"},{"key":"10.1016\/j.vaccine.2019.02.022_b0020","unstructured":"CDC. 2016 Sexually Transmitted Diseases Surveillance; 2018. https:\/\/www.cdc.gov\/std\/stats16\/syphilis.htm."},{"key":"10.1016\/j.vaccine.2019.02.022_b0025","unstructured":"Canadian sexually transmitted infections surveillance report. Can Commun Dis Rep 2007;33(Suppl 1): 1\u201369."},{"issue":"1","key":"10.1016\/j.vaccine.2019.02.022_b0030","doi-asserted-by":"crossref","DOI":"10.1097\/QCO.0b013e32834204bf","article-title":"China's syphilis epidemic: epidemiology, proximate determinants of spread, and control responses","volume":"24","author":"Tucker","year":"2011","journal-title":"Curr Opin Infect Dis"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2019.02.022_b0035","first-page":"S12","article-title":"Global prevalence and incidence estimates of selected curable STDs","volume":"74","author":"Gerbase","year":"1998","journal-title":"Sex Transm Infect"},{"issue":"3","key":"10.1016\/j.vaccine.2019.02.022_b0040","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1067\/S0002-9378(03)00470-8","article-title":"The infectious origins of stillbirth","volume":"189","author":"Goldenberg","year":"2003","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.vaccine.2019.02.022_b0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001396","article-title":"Global estimates of syphilis in pregnancy and associated adverse outcomes: analysis of multinational antenatal surveillance data","volume":"10","author":"Newman","year":"2013","journal-title":"PLoS Med"},{"key":"10.1016\/j.vaccine.2019.02.022_b0050","unstructured":"WHO. The global elimination of congenital syphilis: rationale and strategy for action; 2007."},{"issue":"4","key":"10.1016\/j.vaccine.2019.02.022_b0055","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1097\/01.qai.0000127062.94627.31","article-title":"Can population differences explain the contrasting results of the Mwanza, Rakai, and Masaka HIV\/sexually transmitted disease intervention trials?: a modeling study","volume":"37","author":"White","year":"2004","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.vaccine.2019.02.022_b0060","unstructured":"CDC. The national plan to eliminate syphilis in the United States, 1999. Centers for Disease Control and Prevention. Atlanta (GA): U.S. Department of Health and Human Services."},{"issue":"4","key":"10.1016\/j.vaccine.2019.02.022_b0065","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1574-695X.1993.tb00339.x","article-title":"Characterization of the serum requirement for macrophage-mediated killing of Treponema pallidum ssp. pallidum: relationship to the development of opsonizing antibodies","volume":"6","author":"Baker-Zander","year":"1993","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"Pt 9","key":"10.1016\/j.vaccine.2019.02.022_b0070","first-page":"2349","article-title":"The outer membrane of Treponema pallidum: biological significance and biochemical properties","volume":"131","author":"Penn","year":"1985","journal-title":"J Gen Microbiol"},{"issue":"1","key":"10.1016\/j.vaccine.2019.02.022_b0075","doi-asserted-by":"crossref","DOI":"10.3201\/eid0301.970102","article-title":"Surface antigens of the syphilis spirochete and their potential as virulence determinants","volume":"3","author":"Blanco","year":"1997","journal-title":"Emerg Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2019.02.022_b0080","article-title":"Long-term in vitro culture of the Syphilis Spirochete Treponema pallidum subsp pallidum","volume":"9","author":"Edmundson","year":"2018","journal-title":"mBio"},{"issue":"12","key":"10.1016\/j.vaccine.2019.02.022_b0085","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.00834-10","article-title":"Surface immunolabeling and consensus computational framework to identify candidate rare outer membrane proteins of Treponema pallidum","volume":"78","author":"Cox","year":"2010","journal-title":"Infect Immun"},{"issue":"7","key":"10.1016\/j.vaccine.2019.02.022_b0090","article-title":"Fine analysis of genetic diversity of the tpr gene family among treponemal species, subspecies and strains","volume":"16","author":"Centurion-Lara","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"issue":"12","key":"10.1016\/j.vaccine.2019.02.022_b0095","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.70.12.6811-6816.2002","article-title":"Immunization with the N-terminal portion of Treponema pallidum repeat protein K attenuates syphilitic lesion development in the rabbit model","volume":"70","author":"Morgan","year":"2002","journal-title":"Infect Immun"},{"issue":"10","key":"10.1016\/j.vaccine.2019.02.022_b0100","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.71.10.5605-5612.2003","article-title":"Protection against syphilis correlates with specificity of antibodies to the variable regions of Treponema pallidum repeat protein K","volume":"71","author":"Morgan","year":"2003","journal-title":"Infect Immun"},{"issue":"4","key":"10.1016\/j.vaccine.2019.02.022_b0105","doi-asserted-by":"crossref","DOI":"10.1084\/jem.189.4.647","article-title":"Treponema pallidum major sheath protein homologue Tpr K is a target of opsonic antibody and the protective immune response","volume":"189","author":"Centurion-Lara","year":"1999","journal-title":"J Exp Med"},{"issue":"7","key":"10.1016\/j.vaccine.2019.02.022_b0110","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.0902788","article-title":"Antigenic variation in Treponema pallidum: TprK sequence diversity accumulates in response to immune pressure during experimental syphilis","volume":"184","author":"Giacani","year":"2010","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2019.02.022_b0115","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.74.3.1896-1906.2006","article-title":"TprK sequence diversity accumulates during infection of rabbits with Treponema pallidum subsp. pallidum Nichols strain","volume":"74","author":"LaFond","year":"2006","journal-title":"Infect Immun"},{"issue":"6","key":"10.1016\/j.vaccine.2019.02.022_b0120","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1111\/j.1365-2958.2004.04086.x","article-title":"Gene conversion: a mechanism for generation of heterogeneity in the tprK gene of Treponema pallidum during infection","volume":"52","author":"Centurion-Lara","year":"2004","journal-title":"Mol Microbiol"},{"issue":"21","key":"10.1016\/j.vaccine.2019.02.022_b0125","doi-asserted-by":"crossref","DOI":"10.1128\/JB.185.21.6262-6268.2003","article-title":"Sequence diversity of Treponema pallidum subsp. pallidum tprK in human syphilis lesions and rabbit-propagated isolates","volume":"185","author":"LaFond","year":"2003","journal-title":"J Bacteriol"},{"issue":"5","key":"10.1016\/j.vaccine.2019.02.022_b0130","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1001\/jama.2012.6364","article-title":"Number and order of whole cell pertussis vaccines in infancy and disease protection","volume":"308","author":"Sheridan","year":"2012","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.vaccine.2019.02.022_b0135","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.4049\/jimmunol.110.5.1206","article-title":"Immunity in experimental syphilis. VI. Successful vaccination of rabbits with Treponema pallidum, Nichols strain, attenuated by \u03b3- irradiation","volume":"110","author":"Miller","year":"1973","journal-title":"J Immunol"},{"issue":"Suppl 2","key":"10.1016\/j.vaccine.2019.02.022_b0140","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1258\/095646202762226155","article-title":"Vaccine candidates in STD","volume":"13","author":"Fletcher","year":"2002","journal-title":"Int J STD AIDS"},{"issue":"1","key":"10.1016\/j.vaccine.2019.02.022_b0145","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.72.1.338-344.2004","article-title":"Infection with an avirulent phoP mutant of Neisseria meningitidis confers broad cross-reactive immunity","volume":"72","author":"Newcombe","year":"2004","journal-title":"Infect Immun"},{"issue":"5","key":"10.1016\/j.vaccine.2019.02.022_b0150","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.01972-06","article-title":"Live attenuated Streptococcus pneumoniae strains induce serotype-independent mucosal and systemic protection in mice","volume":"75","author":"Roche","year":"2007","journal-title":"Infect Immun"},{"issue":"13\u201314","key":"10.1016\/j.vaccine.2019.02.022_b0155","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1016\/S0264-410X(98)00436-8","article-title":"The attenuated Salmonella vaccine approach for the control of Helicobacter pylori-related diseases","volume":"17","author":"Gomez-Duarte","year":"1999","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2019.02.022_b0160","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.02443-14","article-title":"A bivalent typhoid live vector vaccine expressing both chromosome- and plasmid-encoded Yersinia pestis antigens fully protects against murine lethal pulmonary plague infection","volume":"83","author":"Galen","year":"2015","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2019.02.022_b0165","doi-asserted-by":"crossref","first-page":"25593","DOI":"10.1038\/srep25593","article-title":"Treponema pallidum Lipoprotein TP0435 expressed in Borrelia burgdorferi produces multiple surface\/periplasmic isoforms and mediates adherence","volume":"6","author":"Chan","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2019.02.022_b0170","doi-asserted-by":"crossref","DOI":"10.1002\/9780471729259.mc12a01s7","article-title":"Isolation and laboratory maintenance of Treponema pallidum","author":"Lukehart","year":"2007","journal-title":"Curr Protoc Microbiol"},{"issue":"10","key":"10.1016\/j.vaccine.2019.02.022_b0175","doi-asserted-by":"crossref","DOI":"10.1128\/JB.00159-10","article-title":"Complete genome sequence and annotation of the Treponema pallidum subsp. pallidum Chicago strain","volume":"192","author":"Giacani","year":"2010","journal-title":"J Bacteriol"},{"key":"10.1016\/j.vaccine.2019.02.022_b0180","doi-asserted-by":"crossref","DOI":"10.1002\/9780471729259.mc12c01s4","article-title":"Laboratory maintenance of Borrelia burgdorferi","author":"Zuckert","year":"2007","journal-title":"Curr Protoc Microbiol"},{"issue":"5","key":"10.1016\/j.vaccine.2019.02.022_b0185","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1128\/AEM.02454-06","article-title":"Adaptation of a luciferase gene reporter and lac expression system to Borrelia burgdorferi","volume":"73","author":"Blevins","year":"2007","journal-title":"Appl Environ Microbiol"},{"issue":"25","key":"10.1016\/j.vaccine.2019.02.022_b0190","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.97.25.13865","article-title":"Correlation between plasmid content and infectivity in Borrelia burgdorferi","volume":"97","author":"Purser","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"10.1016\/j.vaccine.2019.02.022_b0195","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1046\/j.1365-2958.2003.03452.x","article-title":"A plasmid-encoded nicotinamidase (PncA) is essential for infectivity of Borrelia burgdorferi in a mammalian host","volume":"48","author":"Purser","year":"2003","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.vaccine.2019.02.022_b0200","doi-asserted-by":"crossref","DOI":"10.1146\/annurev-genet-011112-112140","article-title":"Genetics of Borrelia burgdorferi","volume":"46","author":"Brisson","year":"2012","journal-title":"Annu Rev Genet"},{"issue":"1","key":"10.1016\/j.vaccine.2019.02.022_b0205","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.01124-06","article-title":"Quantitative analysis of tpr gene expression in Treponema pallidum isolates: differences among isolates and correlation with T-cell responsiveness in experimental syphilis","volume":"75","author":"Giacani","year":"2007","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2019.02.022_b0210","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.02891","article-title":"Age-related differential stimulation of immune response by Babesia microti and Borrelia burgdorferi during acute phase of infection affects disease severity","volume":"9","author":"Djokic","year":"2018","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2019.02.022_b0215","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1128\/JB.01973-12","article-title":"Identification of the Treponema pallidum subsp. pallidum TP0092 (\u03c3E) regulon: implications for pathogen persistence in the host and syphilis pathogenesis","volume":"195","author":"Giacani","year":"2013","journal-title":"J Bacteriol"},{"issue":"2","key":"10.1016\/j.vaccine.2019.02.022_b0220","doi-asserted-by":"crossref","first-page":"952","DOI":"10.4049\/jimmunol.169.2.952","article-title":"Segregation of B and T cell epitopes of Treponema pallidum repeat protein K to variable and conserved regions during experimental syphilis infection","volume":"169","author":"Morgan","year":"2002","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2019.02.022_b0225","doi-asserted-by":"crossref","first-page":"454","DOI":"10.4049\/jimmunol.124.1.454","article-title":"Characterization of lymphocyte responsiveness in early experimental syphilis. I. In vitro response to mitogens and Treponema pallidum antigens","volume":"124","author":"Lukehart","year":"1980","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2019.02.022_b0230","doi-asserted-by":"crossref","first-page":"e0003662","DOI":"10.1371\/journal.pntd.0003662","article-title":"Treponema pallidum subsp. pallidum TP0136 protein is heterogeneous among isolates and binds cellular and plasma fibronectin via its NH2-terminal end","volume":"9","author":"Ke","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2019.02.022_b0235","series-title":"Vaccines for biodefense and emerging and neglected diseases","first-page":"1194","article-title":"Syphilis","author":"Giacani","year":"2008"},{"issue":"1","key":"10.1016\/j.vaccine.2019.02.022_b0240","doi-asserted-by":"crossref","DOI":"10.1080\/14760584.2016.1203262","article-title":"Vaccine development for syphilis","volume":"16","author":"Lithgow","year":"2017","journal-title":"Expert Rev Vacc"},{"issue":"9","key":"10.1016\/j.vaccine.2019.02.022_b0245","doi-asserted-by":"crossref","first-page":"4757","DOI":"10.1128\/IAI.67.9.4757-4763.1999","article-title":"T-cell responses to Treponema pallidum subsp. pallidum antigens during the course of experimental syphilis infection","volume":"67","author":"Arroll","year":"1999","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2019.02.022_b0250","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms14273","article-title":"A defined syphilis vaccine candidate inhibits dissemination of Treponema pallidum subspecies pallidum","volume":"8","author":"Lithgow","year":"2017","journal-title":"Nat Commun"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19302178?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19302178?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T20:18:32Z","timestamp":1694636312000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X19302178"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":50,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["S0264410X19302178"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.02.022","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Non-pathogenic Borrelia burgdorferi expressing Treponema pallidum TprK and Tp0435 antigens as a novel approach to evaluate syphilis vaccine candidates","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.02.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}